This webinar will address the regulatory and industry viewpoints on the subject, and the rationale why each organization, as part of its risk management program, should assess the hazard that raw materials pose to its products and manufacturing processes. Ultimately, the focus should be on both patient safety and regulatory requirements.
Duration: 75 Minutes
Group of 3 to 5
Group of 6 to 10
Physical CD-DVD of recorded session will be despatched after 72 hrs on completion of payment
Recorded video session
Henry Urbach is the founder of GMP Training, Development and Consulting. GMP TDC LLC is a New York-based consulting organization serving Life Sciences industries. Henry has 25+ years of Life Sciences experience having held positions of increased responsibility in GMP Training and QC Microbiology. His experience includes managing GMP compliance and quality systems training, implementing a training program as part of a post-regulatory action remediation, and developing a contamination control and environmental monitoring training program for major pharmaceutical and biotechnology organizations. He is a dynamic speaker specializing in FDA and ICH compliance. He is also a CQA Certified Quality Auditor. His technical education is further complemented by his BA degree in Biology and MBA, which provide a scientific and business insight. He is a member of the ASTD, ASQ, and GMP TEA, a national organization of Life Sciences training professionals.